Schilde T, Kohlhaas M, Spoerl E, Pillunat L E
Universitäts-Augenklinik Carl Gustav Carus, Fetscherstrasse 74, 01307, Dresden, Germany.
Ophthalmologe. 2008 Feb;105(2):165-9. doi: 10.1007/s00347-007-1587-9.
It has been shown that the treatment of keratoconus with riboflavin/ultraviolet A (UVA) causes significant stiffening of the cornea due to cross-linking. The aim of this study was to evaluate how deep the mechanical stabilization after collagen cross-linking could be shown biochemically.
Ten out of 20 enucleated porcine eyes were treated with riboflavin as a photosensitizer and UVA (370 nm, 3 mW/cm2, 30 min). The other 10 eyes served as controls. With a Microkeratom device, two flaps with a thickness of 200 microm and a diameter of 8 mm were cut off from each eye and put in a collagenase solution (NaCl plus collagenase A, 1:1). The surfaces of the flaps were measured digitally every day to characterize the dissolving behavior.
The resistance (regarding corneal collagen against enzymatic digestion) of the treated superficial flaps was considerably higher (p=0.001) compared to those that were cut secondarily and to the control flaps. But even the flaps from deeper layers showed a significant increase in resistance (p=0.02) compared with the untreated flaps. The half-life of the surfaces of the treated superficial flaps was 220 h; of those cut secondarily, it was 80 h. Both untreated flaps had a half-life of 50 h.
The biochemical study showed that the treatment of the cornea with riboflavin/UVA leads to significant collagen cross-linking not only in the anterior slice of 200 microm but also in the following 200 microm. This locally limited cross-linking effect may be explained by the absorption behavior for UVA of the riboflavin-treated cornea; 65% of UVA irradiation is absorbed in the first 200 microm and only 25-30% in the next 200 microm. Therefore, deeper-lying structures and especially the endothelium are not affected.
已表明用核黄素/紫外线A(UVA)治疗圆锥角膜会因交联作用导致角膜显著变硬。本研究的目的是评估胶原交联后机械稳定性在生化方面能显示多深。
20只摘除的猪眼中,10只眼用核黄素作为光敏剂并接受UVA(370纳米,3毫瓦/平方厘米,30分钟)治疗。另外10只眼作为对照。用微型角膜刀从每只眼中切下两片厚度为200微米、直径为8毫米的角膜瓣,放入胶原酶溶液(氯化钠加胶原酶A,1:1)中。每天对角膜瓣表面进行数字测量以表征溶解行为。
与二次切下的角膜瓣及对照角膜瓣相比,经治疗的表层角膜瓣的抵抗力(关于角膜胶原对酶消化的抵抗力)显著更高(p = 0.001)。但即使是深层的角膜瓣与未治疗的角膜瓣相比,抵抗力也显著增加(p = 0.02)。经治疗的表层角膜瓣表面的半衰期为220小时;二次切下的角膜瓣表面半衰期为80小时。两个未治疗的角膜瓣半衰期均为50小时。
生化研究表明,用核黄素/UVA治疗角膜不仅会在200微米的前层切片中导致显著的胶原交联,在接下来的200微米中也是如此。这种局部受限的交联效应可能由核黄素处理过的角膜对UVA的吸收行为来解释;65%的UVA辐射在前200微米被吸收,在接下来的200微米中仅25 - 30%被吸收。因此,更深层的结构尤其是内皮不受影响。